Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis

OBJECTIVE: Accelerated brain volume loss has been noted following immunoablative autologous hematopoietic stem cell transplantation (IAHSCT) for multiple sclerosis. As with other MS treatments, this is often interpreted as ‘pseudoatrophy’, related to reduced inflammation. Treatment‐related neurotoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Thebault, Simon, Lee, Hyunwoo, Bose, Gauruv, Tessier, Daniel, Abdoli, Mohammad, Bowman, Marjorie, Berard, Jason, Walker, Lisa, Rush, Carolina A., MacLean, Heather, Booth, Ronald A., Narayanan, Sridar, Arnold, Douglas L., Tabard‐Cossa, Vincent, Atkins, Harold L., Bar‐Or, Amit, Freedman, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261754/
https://www.ncbi.nlm.nih.gov/pubmed/32304358
http://dx.doi.org/10.1002/acn3.51045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261754/
https://www.ncbi.nlm.nih.gov/pubmed/32304358
http://dx.doi.org/10.1002/acn3.51045

Ejemplares similares